DUBLIN, January 13, 2014 /PRNewswire/ --
Dublin - Research and Markets (http://www.researchandmarkets.com/research/z9vdmc/telemedicine_and) has announced the addition of Wintergreen Research, Inc's new report "Telemedicine and M-Health Convergence: Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2019" to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Clinical telemedicine services converge with m-health systems of engagement to lower cost of care and improve quality of care. Tele-medicine and M-Health Market Convergence driving forces relate to an overall trend toward ordinary people taking more responsibility for their own health. This trend has been more prevalent for women in the past 100 years than for men because women used to die very young and they had to learn how to keep themselves healthy. Women have been able to reverse this trend of dying young and to live longer than men in the past 40 years, illustrating that paying attention to health is important.
Healthcare patient, physician, and facility decision support markets are forecast based n the broad availability of smartphones combined with the IBM Watson technology that Watson offers Interactive Care Insights for Oncology. The cognitive systems use insights gleaned from the deep experience of Memorial Sloan-Kettering clinicians. Watson is positioned to permit clinicians to provide individualized treatment.
More options are based on patient medical information. IBM Watson in combination with Memorial Sloan-Kettering Cancer Center has information that represents the synthesis of a vast array of updated and vetted treatment. It is able to compute individual treatment guidelines. This represents a revolution in cancer treatment care and presages a major revolution in all healthcare treatment and diagnosis.
Because Watson is able to leverage published research it can stay more current than any clinician or group of clinicians can. Watson-is a cognitive computing system. The aim of Watson is to streamline the healthcare delivery process. Watson supports the healthcare decision making process. The system has the ability to ensure evidence-based care is provided.
Both tele-medicine and m-health contribute to healthcare delivery in the home. M-health will surely be delivered over the smart phone. Tele-medicine is evolving toward smart phone device delivery as well. The cost of tele-medicine for the US veterans' administration is $1,600 per patient per annum. This is substantially less than other NIC programs and nursing home care which can easily run to $100,000 per annum. VHA's experience is that an enterprise-wide home tele-medicine implementation is an appropriate and cost-effective way of managing chronic care patients in both urban and rural settings.
Key Topics Covered:
1. Telemedicine Market Description And Market Dynamics
2. Tele-Medicine / M-Health Market Shares And Market Forecasts: Condensed Version
3. Telemedicine / M-Health Product Description
4. Tele-Monitor Technology
5. Telemedicine / M-Health Company Profiles
- Care Innovations / Intel® / GE Bosch Group
- Partners Healthcare
- Veteran's Administration (VA)
- Visiting Nurse Service
For more information visit http://www.researchandmarkets.com/research/z9vdmc/telemedicine_and
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets